BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,926 | -27.9% | 4,794 | -13.0% | 0.02% | -25.0% |
| Q2 2023 | $250,990 | +23.4% | 5,509 | +9.9% | 0.03% | +14.3% |
| Q1 2023 | $203,408 | +81263.2% | 5,015 | +2.1% | 0.03% | -24.3% |
| Q4 2022 | $250 | -99.9% | 4,913 | -7.4% | 0.04% | -19.6% |
| Q3 2022 | $286,000 | -17.8% | 5,307 | -1.9% | 0.05% | -14.8% |
| Q2 2022 | $348,000 | -39.2% | 5,412 | -26.6% | 0.05% | -39.3% |
| Q1 2022 | $572,000 | -44.8% | 7,371 | -39.0% | 0.09% | -37.8% |
| Q4 2021 | $1,037,000 | +5.8% | 12,078 | -0.9% | 0.14% | 0.0% |
| Q3 2021 | $980,000 | +0.2% | 12,190 | +0.3% | 0.14% | -3.4% |
| Q2 2021 | $978,000 | -2.7% | 12,149 | +1.9% | 0.15% | -9.2% |
| Q1 2021 | $1,005,000 | +5.7% | 11,922 | +0.5% | 0.16% | +1.9% |
| Q4 2020 | $951,000 | -0.9% | 11,864 | -0.6% | 0.16% | -13.5% |
| Q3 2020 | $960,000 | +12.0% | 11,939 | +21.4% | 0.18% | +2.8% |
| Q2 2020 | $857,000 | -18.7% | 9,833 | -24.3% | 0.18% | -34.1% |
| Q1 2020 | $1,054,000 | -2.6% | 12,994 | +0.4% | 0.27% | +35.8% |
| Q4 2019 | $1,082,000 | +10.2% | 12,948 | +15.3% | 0.20% | +3.6% |
| Q3 2019 | $982,000 | +0.2% | 11,229 | -6.2% | 0.19% | -2.0% |
| Q2 2019 | $980,000 | -5.5% | 11,971 | -6.1% | 0.20% | -8.3% |
| Q1 2019 | $1,037,000 | +25.8% | 12,755 | +1.9% | 0.22% | +10.2% |
| Q4 2018 | $824,000 | -7.6% | 12,520 | +8.2% | 0.20% | +7.7% |
| Q3 2018 | $892,000 | +11.1% | 11,572 | +6.3% | 0.18% | +4.6% |
| Q2 2018 | $803,000 | +6.5% | 10,882 | -6.2% | 0.17% | +5.5% |
| Q1 2018 | $754,000 | -1.2% | 11,596 | -1.8% | 0.16% | +2.5% |
| Q4 2017 | $763,000 | -65.0% | 11,806 | -66.0% | 0.16% | -66.0% |
| Q3 2017 | $2,177,000 | -3.1% | 34,700 | -6.5% | 0.47% | -3.3% |
| Q2 2017 | $2,246,000 | +47.0% | 37,104 | +25.9% | 0.49% | +38.8% |
| Q1 2017 | $1,528,000 | +17.6% | 29,465 | +0.5% | 0.35% | +13.5% |
| Q4 2016 | $1,299,000 | -4.6% | 29,311 | +2.5% | 0.31% | -6.3% |
| Q3 2016 | $1,361,000 | +3.7% | 28,601 | -1.5% | 0.33% | -2.6% |
| Q2 2016 | $1,312,000 | +10.6% | 29,036 | +0.5% | 0.34% | +6.2% |
| Q1 2016 | $1,186,000 | +8.4% | 28,892 | +0.6% | 0.32% | +2.9% |
| Q4 2015 | $1,094,000 | +14.8% | 28,722 | -1.0% | 0.31% | +9.5% |
| Q3 2015 | $953,000 | +557.2% | 29,022 | +1339.6% | 0.28% | +481.6% |
| Q3 2014 | $145,000 | 0.0% | 2,016 | +0.7% | 0.05% | +4.3% |
| Q2 2014 | $145,000 | +2.8% | 2,002 | +4.4% | 0.05% | -11.3% |
| Q1 2014 | $141,000 | -77.5% | 1,917 | -78.7% | 0.05% | -79.0% |
| Q4 2013 | $627,000 | +5.6% | 9,020 | -0.2% | 0.25% | -6.3% |
| Q3 2013 | $594,000 | -6.2% | 9,040 | -1.0% | 0.27% | -7.6% |
| Q2 2013 | $633,000 | 0.0% | 9,131 | 0.0% | 0.29% | 0.0% |
| Q1 2013 | $633,000 | – | 9,131 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |